20 fast tests for $569.00
Due to the highly contagious nature and global spread, SARS-CoV-2 has been designated as a pandemic by the World Health Organization (WHO) and continues to have devastating impacts on healthcare systems and the world economy including the U.S. To effectively end the SARS-CoV-2 pandemic, systematic screening and detection of both clinical and asymptomatic COVID-19 cases is critical. As an intended point-of-care (POC) designated test with a 10 minute processing time, CareStart™ COVID-19 Antigen Test allows effective screening of COVID-19 infection in symptomatic patients on a large scale.
Features Clinical Features ━ Lateral flow assay ━ Rapid results in 10 minutes ━ Nasopharyngeal specimen collection ━ Intended at POC setting (i.e., in patient care settings) by medical professionals with a CLIA waiver ━ Detect SARS-CoV-2 nucleocapsid protein antigen ━ Identify acute infection with 88.4% sensitivity and 100% specificity ━ Storage condition : 1-30 degrees celsius
The CareStartTM COVID-19 Antigen Test is a lateral flow immunochromatographic assay for the detection of extracted
nucleocapsid protein antigens specific to SARS-CoV-2 in swab specimens directly collected from symptomatic individuals who are
suspected of COVID-19 by their healthcare providers.
SARS-CoV-2 antigen present does
not rule out co-infection with other
pathogens. The color intensity in the
test region will vary depending on
the amount of SARS-CoV-2 antigen
present in the sample. Any faint
colored line(s) in the test region(s)
should be considered as positive.
Negative test results do not preclude
infection and should not be used
as the sole basis for treatment or
other patient management decisions,
including infection control decisions.
It is recommended that these
results be conrmed by a molecular
testing method, if necessary for
Re-run the test one time using the
remaining specimen in the extraction
vial if an invalid result is obtained
during initial testing.